Oya M - Search Results

1

Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions.

Arita Y, Shigeta K, Akita H, Suzuki T, Kufukihara R, Kwee TC, Ishii R, Mikami S, Okuda S, Kikuchi E, Oya M, Jinzaki M. Arita Y, et al. Among authors: oya m. Eur Radiol. 2021 Feb;31(2):875-883. doi: 10.1007/s00330-020-07153-5. Epub 2020 Aug 23. Eur Radiol. 2021. PMID: 32829418

2

Suppression of hormone-refractory prostate cancer by a novel nuclear factor kappaB inhibitor in nude mice.

Kikuchi E, Horiguchi Y, Nakashima J, Kuroda K, Oya M, Ohigashi T, Takahashi N, Shima Y, Umezawa K, Murai M. Kikuchi E, et al. Among authors: oya m. Cancer Res. 2003 Jan 1;63(1):107-10. Cancer Res. 2003. PMID: 12517785

3

Differential expression of activator protein-2 isoforms in renal cell carcinoma.

Oya M, Mikami S, Mizuno R, Miyajima A, Horiguchi Y, Nakashima J, Marumo K, Mukai M, Murai M. Oya M, et al. Urology. 2004 Jul;64(1):162-7. doi: 10.1016/j.urology.2004.02.022. Urology. 2004. PMID: 15245963

4

Three-dimensional ultrasonography in evaluation of benign prostatic hyperplasia.

Kanao K, Kikuchi E, Nakashima J, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Marumo K, Murai M. Kanao K, et al. Among authors: oya m. Int J Urol. 2004 Dec;11(12):1087-91. doi: 10.1111/j.1442-2042.2004.00950.x. Int J Urol. 2004. PMID: 15663680 Free article. Clinical Trial.

5

C-jun activation in acquired cystic kidney disease and renal cell carcinoma.

Oya M, Mikami S, Mizuno R, Marumo K, Mukai M, Murai M. Oya M, et al. J Urol. 2005 Aug;174(2):726. doi: 10.1097/01.ju.0000164656.99251.77. J Urol. 2005. PMID: 16006965

6

Expression of Ets-1 in human clear cell renal cell carcinomas: implications for angiogenesis.

Mikami S, Oya M, Mizuno R, Murai M, Mukai M, Okada Y. Mikami S, et al. Among authors: oya m. Cancer Sci. 2006 Sep;97(9):875-82. doi: 10.1111/j.1349-7006.2006.00268.x. Epub 2006 Jul 13. Cancer Sci. 2006. PMID: 16856880 Free PMC article.

7

Usefulness of alpha1-antichymotrypsin-PSA complex for predicting bone metastases of prostate cancer.

Kikuchi E, Nakashima J, Ishibashi M, Ohigashi T, Oya M, Nakagawa K, Miyajima A, Murai M. Kikuchi E, et al. Among authors: oya m. Urology. 2006 Aug;68(2):371-5. doi: 10.1016/j.urology.2006.02.031. Urology. 2006. PMID: 16904455

8

Assessment of long-term quality of life using the FACT-BL questionnaire in patients with an ileal conduit, continent reservoir, or orthotopic neobladder.

Kikuchi E, Horiguchi Y, Nakashima J, Ohigashi T, Oya M, Nakagawa K, Miyajima A, Murai M. Kikuchi E, et al. Among authors: oya m. Jpn J Clin Oncol. 2006 Nov;36(11):712-6. doi: 10.1093/jjco/hyl094. Epub 2006 Oct 3. Jpn J Clin Oncol. 2006. PMID: 17018576

9

Interleukin 6 is associated with cachexia in patients with prostate cancer.

Kuroda K, Nakashima J, Kanao K, Kikuchi E, Miyajima A, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Murai M. Kuroda K, et al. Among authors: oya m. Urology. 2007 Jan;69(1):113-7. doi: 10.1016/j.urology.2006.09.039. Urology. 2007. PMID: 17270630

10

Clinical implications of tumor size and local extent of primary prostatic lesions in prostate cancer patients with metastases: value of endorectal magnetic resonance imaging in patients with metastases.

Nakashima J, Tanimoto A, Kikuchi E, Miyajima A, Nakagawa K, Oya M, Ohigashi T, Murai M. Nakashima J, et al. Among authors: oya m. Urology. 2007 Jul;70(1):86-90. doi: 10.1016/j.urology.2007.03.005. Urology. 2007. PMID: 17656214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,236 results

Search Page

Filters